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INTRODUCTION

Cancer Overview
Cancer is a heterogeneous group of diseases characterized by uncontrolled cell growth, invasion with destruction of adjacent tissue, and sometimes metastasis, or spreading to other bodily locations via lymph or blood. If untreated, this uncontrolled growth and spread may result in death. It is estimated that over 1,529,000 non-dermal related cancers will be diagnosed in the United States. 1 Of these, it is estimated that approximately 570,000 will succumb to the disease, making cancer the second most common cause of death in the United States, second only to heart disease. 2 Head and neck cancers are a related group of cancers that involve the oral cavity, pharynx and larynx. Globally, approximately 600,000 new cases of head and neck cancers are diagnosed yearly, resulting in approximately 300,000 deaths. 1 This ranks head and neck cancer as the sixth most common cancer worldwide, and third among developing countries. 3, 4 The majority of head and neck cancers are squamous cell carcinoma in histology, with approximately 94% of all oral malignancies being squamous cell carcinoma. 5 Like most cancers, the cause of head and neck cancers are multifactorial. No single causative agent or factor (carcinogen) has been clearly defined or accepted. This has lead many investigators to propose the concept of cocarcinogenisis, in which extrinsic and intrinsic factors are needed to produce a malignancy. 6 Tobacco smoking is the greatest extrinsic factor for head and neck cancer, with a higher risk for heavy and chronic smokers. Consumption of alcoholic beverages also increases the risk, with heavy drinkers having a tenfold risk. The combination of smoking and alcohol seems to have synergistic effect, further increasing the risk. 6 Other extrinsic risk factors include betel quid and acrea nut in India and Taiwan 7,8 , inorganic acid mists containing sulfuric acid and mustard gas produced in manufacturing processes 9 , as well as poor oral health and frequent use of mouthwash. 10 Large epidemiological studies have also shown human papilloma virus (HPV) as a causative agent of some head and neck cancers. HPV markers have been by identifying HPV DNA in biopsy tissues via polymerase chain reaction (PCR) methods, antibodies to HPV 16 capsids analyzed with enzyme linked immunosorbent assay (ELISA), and antibodies to HPV 16 E6 and E7 analyzed by ELISA.
Epigenetics
While the majority of extrinsic and intrinsic factors directly effect the genome, the study of cancer epigenetics has reached mainstream oncology. 11 The field of epigenetics is an expanding and promising field that has expanded our knowledge on the importance of epigenetic events in the control of both normal cellular processes and abnormal events associated with diseases. Conrad Waddington coined the term "epigenetics" in 1942 to describe the discipline in biology that studies "the interactions of genes with their environment that bring the phenotype into being." 12 This definition initially referred to the role of epigenetics in reference to embryonic development only; however, since that time, it has evolved and implicated in a number of biological events that are not coded in the DNA sequence itself, namely imprinting, position-effect variegation, paramutations, and X-chromosome inactivation. 13 The current definition of epigenetics is "the study of heritable changes in gene expression that occur independent of changes in the primary DNA sequence". Thus, in the broadest sense, epigenetics represents an interface between genotype and phenotype in that it embodies the mechanism that modifies the final outcome of the genetic code without altering the code itself. The importance and validity of epigenetics is evident by the fact that all cells in any given organism share an identical genome, yet have specific functional and morphological characteristics.
Expanding on this principle that epigenetics is a conduit between genotype and phenotype, epigenetics can be viewed as the changes that are stably transmitted over many rounds of cell division, but that do not alter the nucleotide sequence. Major epigenetic mechanisms can be divided into four main categories: DNA methylation, covalent histone modifications, non-covalent mechanisms such as incorporation of histone variants and nucleosome remodeling, and non-coding RNAs including microRNAs (miRNAs). 13 It is these mechanisms that allow such a stable propagation of gene activity states from one generation of cells to the next. This epigenetic activity is essential for embryonic development, cell differentiation, and could be the mechanism of integration of endogenous and environmental signals during the life of an organism. [14] [15] [16] Analogously, it is important to note that the deregulation of epigenetic states is intimately linked to human diseases, most notably cancer. [15] [16] [17] DNA Methylation DNA methylation and histone acetylation and methylation are the major epigenetic modifications that are most intensively studied in the context of gene transcription and abnormal events that lead to oncogenesis. 15, 17 Once the epigenetic modifications have been established, they are autonomously propagated through cell lines. It has been shown that disruption of one of these two epigenetic mechanisms inevitably affects the other. 18-21 For example, hypermethylation of CpG islands in gene promoters triggers deacetylation of local histones, whereas lower levels of histone acetylation (hypoactelyation) seem to predispose to target DNA methylation. Therefore, there appears to be an intimate relationship between the mechanisms. However, the overlying hierarchical order of epigenetic events during gene silencing in tumor cells is yet to be determined.
DNA methylation is perhaps the most extensively studied epigenetic mechanism. 13 The methylation of DNA refers to the covalent addition of a methyl group to the 5-carbon (C 5 ) position of cytosine bases, yielding 5-mehtylcytosine (5-meC) .
While this does not alter the DNA sequence directly, it may have major consequences on gene regulation by acting as a stable gene silencing mechanism. In mammals, DNA methylation occurs in regions where a cytosine nucleotide occurs next to a guanine nucleotide in a linear sequence. These "CpG" (-C-phosphate-G-) dinucleotides are not randomly distributed within the genome, but rather tend to occur in CpG-rich stretches (~300-3000 base pairs in length) representing "CpG islands". These regions of repetitive sequences are found in centromeres, retrotransposon elements, and rDNA. 22, 23 Notably, these islands are preferentially located at the 5' end of genes and occupy ~60% of human gene promoters. 24 From a regulatory standpoint, DNA methylation serves as a repressive mechanism inhibiting gene transcription. This primarily occurs through two mechanisms. The first involves direct interference with transcription factor binding. Methylation of CpG nucleotides prevents normal binding of these proteins to DNA, and thus inhibits gene transcription. (Figure 1-1) The second mechanism involves the recruitment and binding of specialized methyl-DNA binding proteins. These proteins bind to 5-meC bases and serve as a protein scaffold that recruits transcription repression factors, as well as families of histone modifying enzymes. represents an attractive target for early diagnosis, risk assessment, and cancer prevention. [30] [31] [32] [33] Genomic DNA is packaged into a highly compacted DNA-protein complex, called chromatin. It functions to pack DNA into a smaller volume within the cell structure, to strengthen the DNA, coordinate mitosis, and to serve as a control of gene expression and DNA replication. This DNA-protein complex is often divided into two distinct forms: heterochromatin, a condensed and highly repressive form, and euchromatin, a more "relaxed" form that can be generally permissive for transcription.
Chromatin is made of repeating units of nucleosomes, which consists of ~146 base pairs of DNA wrapped 1.6 times around an octamer of four core histone proteins. This octamer is composed of two H3-H4 histone dimers bridged together as a stable tetramer that is flanked by two separate H2A-H2B dimers. (Figure 1 
Histone Acetylation
Acetylation is a reaction that introduces an acetyl functional group into a chemical compound. Specifically, it involves the substitution of an acetyl group for an active hydrogen atom. Acetylation of lysine residues on histone tails is controlled via two types of enzymes: histone acetyltransferases (HATs) and histone deacetylases (HDACs).
HATs use acetyl-CoA to transfer an acetyl group on the N-terminal tails of histones 40 , while HDACs reverse this modification. 41, 42 Most HATs come in the form of large multiprotein complexes with various complexes ensuring locus targeting and chromosomal-domain and substrate-specificity. 43 Similarly, HDACs are also composed of large multiprotein complexes. The dynamic equilibrium, and ultimately gene availability and expressivity, is governed by the opposing actions of HATs and HDACs.
Within the histone octamer, positively charged histone tails protrude out from the central domain of the nucleosome (Figure 1-2) and are believed to bind the negatively charged DNA through charge interactions or mediate interactions between nucleosomes contributing in chromatin compaction. 36, 44 Lysine acetylation is believed to neutralize the positive charge of histone tails, weakening histone-DNA 45 or nucleosome-nucleosome interactions. 44, 46 This results in destabilizing nucleosome and chromatin structure, thus (Figure 1-4) . It is an analogue of the straight chain valeric acid (C 5 H 10 O 2 ), which is found in naturally in the perennial flowering plant valerian (Valeriana officinalis). Valproic acid was thought to be physiologically inert until 1963
when it was used as a molecular carrier that prevented pentylenetetrazol-induced convulsions in rodents. 49 In the human brain, VPA increases the function of the neurotransmitter gamma-Aminobutyric acid (GABA) by increasing synthesis of GABA, inhibiting GABA degradation and decreasing GABA turnover. 50 Moreover, VPA blocks Na + channels, Ca 2+ channels, and voltage-gated K + channels. 51 Clinically, VPA can be used as an anticonvulsant and moodstabilizing drug, but also to control absence seizures, tonic-clonic seizure, complex partial seizures, seizures associated with Lennox-Gastaut syndrome, and schizophrenia. Additionally, VPA has been noted for its HDAC inhibitory abilities, which allows it to alter expression of genes. It has also been shown that VPA has the ability to induce methylation of histone 3, with this occurring primarily at lysine 9. 52-54 Methylation at this histone site is associated with increased transcriptional activity. Thus, the use of VPA as an epigenetic drug is encouraging because it targets chromatin through associated proteins and may be applicable to a wide range of pathologic processes, especially cancer. Specifically epigenetic drugs could be used to target repressed tumor suppressor genes. To date, VPA's antitumor effects have been used in pre-clinical studies to treat glioma, [55] [56] [57] neuroblastoma, 57,58 breast cancer, 59,60 colon cancer, [61] [62] [63] prostate cancer, 64, 65 thyroid cancer, [66] [67] [68] cervical cancer, 69 melanoma, 70 ovarian cancer, 71 
Hypothesis
There is a direct relationship between VPA administration and histone acetylation. The null hypothesis (H 0 ) being that VPA will not have an affect on histone acetylation, and the alternative hypothesis (H a ) is that there is a difference in the means. VPA was prepared as a 100mM stock solution in water and stored at -20°C. Cells were maintained in exponential growth phase until experiments were performed with cells that were plated at a cell density of 5 x 10 5 cells per 100mm dish. Cells were then allowed to grow for 24 hours before treatments. In complete DMEM media, VPA was then added in concentrations of 0.02mM, 0.1mM, 0.5mM, 2.5mM, and 12.5mM and incubated at 37° for 48 hours with no additional drug given.
MATERIALS AND METHODS
Cell
Histone Extraction
Following incubation, cells were harvested and histones were extracted using the following protocol.
1) Cells were harvested via scraping from plates with phosphate buffered saline (PBS) and centrifuged at 500 x g at 4°C, obtaining a pellet.
2) The pellet was washed again with 10mL PBS and spun again. The pellet was resuspended in 1 mL hypotonic lysis buffer and transferred to 1.5mL tubes.
3) The tubes were then placed on a rotator at 4°C for 30 minutes to promote hypotonic swelling of cells and lysis by mechanical shearing during rotation.
4)
A pellet was then obtained by spinning on a tabletop centrifuge at 10,000x g for 10 minutes at 4°C.
5)
The supernatant was discarded, and this process was repeated with another 1 mL of lysis buffer and rotated for and additional 30 minutes.
6) The supernatant was again discarded, and the remaining pellet was re-suspended in 800 μL 0.4 N H 2 SO 4 .
7)
The suspension is vortexed and placed on rotator overnight. 8) Nuclear debris was removed by spinning samples in tabletop centrifuge at for 10 minutes at 16,000 x g at 4°C.
Histone Precipitation 1) The supernatant was transferred to 1.5mL tubes and 132 μL of 100% (trichloracetic acid) (TCA) was added drop by drop.
2) The solution was cooled on ice for 30 minutes.
3) The suspension was then centrifuged for 10 minutes at 16,000 x g at 4°C.
4) The supernatant was removed and the remaining pellet was washed with 1mL 100% ice-cold acetone.
5)
The pellet was again centrifuged for 10 minutes at 16,000 x g at 4°C.
6) The pellet was again washed and centrifuged (repeating steps 4 and 5).
7)
The histone pellet was air dried for 20 minutes at room temperature and then dissolved with tris buffer 10mM, pH 8.
Histone Quantification
The concentration of each sample was obtained using a Bradford protein assay.
The procedure is as follows:
1) Bovine serum albumin (BSA) at a concentration of 10mg/mL was diluted 1:10 to obtain a final concentration of 1mg/mL. 
Western Blot Analysis
Proteins quantified on the Bradford assay were run on a SDS-PAGE gel. H3, acetylated H3 (acH3), and acetylated H3 only lysine position 9 (acH3-K9) were run for separation of different-sized proteins. The procedure is as follows:
1) 12% gels were constructed with the following recipe (Table 1) : 
7)
Chemiluminssescent substrate was added to the blot for exposure of products, and film was exposed and qualitatively quantified for protein amount.
Statistics
Data are expressed as means and standard deviation. All experiments were performed at least three different cell cultures. Significance between drug levels was analyzed by analysis of variance (one way). A p-value of less than 0.05 was considered significant.
RESULTS
A total of three experiments examining the effect of VPA at various concentration levels (0.0 mM (mock), 0.02 mM, 0.1 mM, 0.5 mM, 2.5 mM, 12.5 mM) on histone acetylation. Specifically, acetylated H3 (acH3) levels and acetylated H3 levels at lysine position 9 (acH3K9) were examined and compared with the overall histone levels. The findings demonstrated the following:
1. Treatment with VPA shows a qualitative trend in accumulation of acetylated histones.
2. This positive relationship is dose dependent.
3.
A one-way ANOVA model was created for each drug level. No statistically significant difference on histone acetylation with VPA treatment was found (p=0.309 acH3, p=0.296)
Western blot analysis was used to detect specific proteins by using gel electrophoresis to separate acetylated H3 and acetylated H3 K9 proteins. After transfer to a nitrocellulose membrane, specific secondary antibodies marked these proteins.
Chemiluminescent detection was used to capture a digital image of the Western blot.
( Figures 5, 6 , and 7) This image was analyzed by densitometry, yielding quantities based on optical density. Quantities were normalized in relation to mock levels ( Table 2 and Table 3 ), and there was found to be a direct relationship with VPA levels and histone acetylation (Figure 3-4 ). Levels of acetylated H3 and acetylated H3 K9 were compared to total H3 (figure [3] [4] [5] VPA (mM) Protein increases as VPA levels increase, with the highest protein levels (darkest band) at 12.5 mM of VPA. C) Acetylated H3 at lysine position 9: Protein levels increase as VPA level increase, with the highest protein levels (darkest intensity bands) at 12.5 mM of VPA. There is a trend between acetylation and higher levels of VPA concentration. 88 , lung 89 , cervical 90 , gastric 91 , and hepatocellular 92 cancer cell lines. This is, to our knowledge, the first such trend investigated and demonstrated in head and neck cell lines using VPA.
Mock
AcH3K9/AcH3
Analysis of Variance (One-Way) AcH3/H3
Although the ANOVA failed to show a difference in any of the means, the sample size and the effect size was small to modest. Also of note, the variance was high within the samples. With an increased number of experiments, and thus higher power, it would be expected that the trend seen would manifest as significance. Reducing the variance with improved laboratory technique and a compressed time schedule would also allow for significant results. This would allow for more consistent laboratory techniques as well as allowing for usage of materials from the same sample stock, reducing external variability.
Reducing variance could also be obtained by utilizing more sensitive detection techniques such as individual protein immunoprecipitation (IP) or chromatin immunoprecipitation methods (ChIP).
Future Directions
Radiation is a well-established and widely used therapy modality to treat cancer worldwide. Data indicates that approximately 50% of cancer patients are treated with radiation for either therapeutic or palliative purposes. 93 It is clear that the therapeutic index of radiotherapy can be improved with the use of chemical agents that sensitize cancer cells to the toxic effects of ionizing radiation. Therefore, the development of such compounds with the purpose of cell sensitization to radiation has been pursued. Recently, it has been reported that VPA possesses radiation sensitizing properties both in vitro and in vivo. 94 It was believed that histone hyperacetylation and the radiation sensitizing mechanism suppressed DNA repair leading to cell death. Given these findings, further studies can be done on head and neck squamous cell carcinoma FaDu-luc cells to investigate the correlation of enhancement of radiation-induced cell-death by VPA. This is not only to elucidate applications for head and neck cancers, but also to confirm treatment modalities for other applications as well.
The radiosensitizing effects of VPA could be investigated with a clonogenic assay. Gerster et al found radiosensity on head and neck squamous cell carcinoma cells at 6 Gy when targeting polo-like kinase 1. 95 Chen et al utilized DNA methyltransferase 1 on FaDU-C225-R cells and also found radiosensitivity at 6 Gy. 96 Given these findings, treatment with VPA on FaDu-luc cells treated with VPA and radiation doses of 0 -12 Gy could be of interest. A sample clonogenic assay could entail administering ionizing radiation (0, 6, 12 Gy) delivered 24 hours after treatment treated with VPA ( 0 -12.5 mM).
Conclusion
VPA has been shown to increase histone acetylation in various cancer cell lines and is actively pursued in clinical trials. To date, VPA has not been utilized for head and neck squamous cell carcinoma therapy. The findings show that VPA has the propensity to act as a HDAC inhibitor and may be used to radiosensitize these cells for higher efficiency of treatment.
